Andrew Norris

Title: Inventor Spotlight: Andrew Norris

Introduction: Andrew Norris, an innovative inventor based in Palmyra, Virginia, has made significant contributions to the field of biomedical research, particularly in the area of breast cancer diagnostics and therapeutics. With two patents to his name, Norris stands out as a dedicated professional committed to advancing medical science through innovation.

Latest Patents: Andrew Norris's latest patents focus on the identification of MHC class I phospho-peptide antigens from breast cancer, utilizing SHLA technology and complementary enrichment strategies. These patents describe novel tumor-specific phosphorylated peptides, along with the nucleic acids encoding them and the antibodies generated against these peptides. The inventions have potential applications as diagnostic indicators for the presence of breast cancer and may also be utilized in therapeutics to treat this challenging disease.

Career Highlights: Throughout his career, Andrew Norris has worked with prestigious organizations such as Agenus Inc. and the University of Oklahoma. His roles in these institutions have allowed him to collaborate with leading experts and contribute to important research initiatives.

Collaborations: Notable collaborations in Norris's career include working alongside esteemed colleagues Donald F. Hunt and Ann Michelle English. These partnerships have fostered a rich environment for innovation and have amplified the impact of his research findings in the medical community.

Conclusion: Andrew Norris's dedication to inventing solutions for breast cancer diagnosis and treatment reflects his passion for science and commitment to improving patient outcomes. With two impactful patents and a collaborative spirit, he continues to pave the way for future innovations in the field of cancer research.